Page 25 - iA Excellence -Field Underwriting Guide - Updated on July 2019
P. 25

POTENTIAL UNDERWRITING DECISION               APS
                    MEDICAL CONDITION
                                                         Life               DI             Life        DI

                Spina bifida
                Spina bifida occulta
                                                  Asymptomatic: Standard                Yes, if offer is
                Present or in history                                     Exclusion                    No
                                                   Symptomatic: Decline                  possible
                Spina bifida – other
                Present                              Rating to Decline     Decline
                                                                       Defer 6 months post   Yes, if offer is   Yes, if
                                                     Defer 6 months,
                In history, operated, no residuals                        operation      possible   necessary
                                                   > 6 months: Standard
                                                                      > 6 months: Exclusion
                                                                                        Yes, if offer is
                In history, operated, with residuals   Rating to Decline   Decline                     No
                                                                                         possible
                Tumours, cancer
                Tumours benign, confirmed by biopsy or other diagnostic test
                                                                       Present or removed:
                Brain or spinal cord             Present or removed: Decline
                                                                           Decline
                                                                       Present: Exclusion to
                                                  Present: Rating to Decline  Defer
                Others (subject to type and location)
                                                 Removed: Usually Standard  Removed: Usually
                                                                          Standard
                                                                        Present: Decline  Yes, if offer is possible
                                                                       Removed or treated:
                                                     Present: Decline  Usually Defer after 5
                Tumours malignant, cancerous, subject to type,        years of last treatment,
                location and time since cancer-free  Removed or treated: Rating
                                                       to Decline           if any
                                                                      > 5 years: Exclusion to
                                                                           Decline
                Skin cancer
                                                                        Present: Decline
                                                 Present: Usually defer after   Removed or treated:
                                                        surgery        1 episode: Usually
                Basal cell carcinoma
                                                 Removed or treated: Usually   Standard
                                                       Standard           More than
                                                                       1 episode: Exclusion
                                                                                          Yes, if offer is possible
                                                                        Present: Decline
                                                                       Removed or treated:
                Melanoma, 1 occurrence, subject to type,   Present: Decline Removed or   Usually defer for 1-5
                location and time since cancer-free  treated: Rating to Decline  years
                                                                       After: Exclusion to
                                                                           Decline










                                                                                                                  25

                                                                                               For exclusive use by Financial Advisors
   20   21   22   23   24   25   26   27   28   29   30